| Literature DB >> 32487032 |
Yoshie Takagi1,2, Takeaki Imamura2,3, Shota Endo1, Kenta Hayashi1, Satoka Akiyama1, Yoji Ikuta1, Takahiro Kawaguchi1, Tomoko Sumita1, Tatsuo Katori1, Masanori Hashino4, Shinji Saito5, Takato Odagiri5, Kunihiro Oba1, Makoto Kuroda4, Tsutomu Kageyama6.
Abstract
BACKGROUND: Neurogenic pulmonary edema is a rare but serious complication of febrile status epilepticus in children. Comprehensive screening for viral pathogens is seldomly performed in the work-up of febrile children. CASEEntities:
Keywords: Co-detection; Febrile status epilepticus; Human coronavirus HKU1; Human parainfluenza virus 2; Influenza C virus; Multiplex real-time RT-PCR; Neurogenic pulmonary edema
Year: 2020 PMID: 32487032 PMCID: PMC7266127 DOI: 10.1186/s12879-020-05115-2
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Fig. 1Chest radiograph findings. a. Revealing bilateral, centrally distributed opacities, without cardiac dilation upon ER arrival. b. Remarkable improvement of lung consolidation can be observed on hospital day 2
Laboratory data upon admission
| Blood test (venous) | Results | Reference |
|---|---|---|
| White blood cells (/μL) | 13,300 | 4000–10,000 |
| Neutrophil (%) | 43 | |
| Lymphocyte (%) | 46 | |
| Monocyte (%) | 10 | |
| Eosinophil (%) | 1 | |
| CRP (mg/dL) | 0.11 | < 0.5 |
| ASTa (U/L) | 76 | 10–40 |
| ALT (U/L) | 25 | 5–45 |
| LDHa (U/L) | 516 | 120–240 |
| Total bilirubin (mg/dL) | 0.3 | 0.2–1.2 |
| NH3 (μg/dL) | 124 | 30–86 |
| Creatinine kinase (U/L) | 131 | 40–150 |
| Ferritin (ng/mL) | 62.5 | 9.0–275 |
| Glucose (mg/dL) | 313 | 70–109 |
| Lactate (mmol/L) | 3.7 | 0.56–1.39 |
| pH | 6.902 | 7.35–7.45 |
| PaCO2 (mmHg) | 137.0 | 35.0–45.0 |
| HCO3− (mmol/L) | 25,6 | 20–26 |
| Base excess (mmol/L) | −12.7 | −3.3 - 2.3 |
a Hemolytic by blood sampling technique
Abbreviations: CRP C-reactive protein, AST aspartate transaminase, ALT alanine transaminase, LDH lactate dehydrogenase
Findings of three types of genetic test assays of nasopharyngeal specimen upon admission
| Real-time RT-PCRa (Cq value) | BIOFIRE FILMARRAY | Metagenomic analysis using NGS; number of reads | |
|---|---|---|---|
Nasopharyngeal specimen Upon admission | Human coronavirus HKU1 (21.5) Influenza C virus (19.7) Human parainfluenza virus 2 (36.4) (16 viruses undetectable) | Human coronavirus HKU1 + Human parainfluenza virus 2 + (12 viruses and 3 bacteria undetectable) | Human coronavirus HKU1 714 reads (0.004%) Influenza C virus 4698 reads (0.026%) Human 16,716,897 reads (93.1%) (No other viruses read) |
Nasopharyngeal specimen Hospital day 2 | Human coronavirus HKU1 (30.0) Influenza C virus (25.9) (17 viruses undetectable) | NE | NE |
| Serum on admission | NE | NE | No viruses read |
| Cerebrospinal fluid upon admission | NE | NE | No viruses read |
a Targeting nineteen respiratory viruses: influenza A (subtype H1pdm and H3), influenza B and C, human metapneumovirus, human respiratory syncytial viruses A and B, human bocavirus, rhinovirus, human respirovirus 1 and 3, human parainfluenza viruses 2 and 4, human adenoviruses 2 and 4, human coronaviruses NL63, OC43, HKU1 and 229E
b Targeting fourteen respiratory viruses: influenza A and B, human metapneumovirus, human respiratory syncytial virus, rhinovirus/enterovirus, human parainfluenza viruses 2 and 4, human adenoviruses 2 and 4, human adenovirus, human coronaviruses NL63, OC43, HKU1 and 229E. Targeted bacteria: Bordetella pertussis, Chlamydophila pneumoniae, Mycoplasma pneumoniae. Influenza C virus was not included in the targeted panel and was thus undetectable
NE not examined. +, positive